MedTrace Logo

Intravenous Iron for Treatment of Anaemia Before Cardiac Surgery

NCT02632760 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 955

Last updated 2026-01-02

No results posted yet for this study

Summary

This randomised double-blind, controlled phase IV trial will compare the efficacy, safety and cost-effectiveness of preoperative IV iron with placebo in patients with anaemia before elective cardiac surgery.

Conditions

  • Anaemia

Interventions

DRUG

Ferric carboxymaltose

treatment for Iron deficient anaemia

DRUG

Placebo

placebo - no active drug

Sponsors & Collaborators

  • National Health and Medical Research Council, Australia

    collaborator OTHER

  • Monash University

    collaborator OTHER

  • Bayside Health

    lead OTHER_GOV

Principal Investigators

  • Paul S Myles, MD · Bayside Health

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-07-15
Primary Completion
2024-04-16
Completion
2024-11-27

Countries

  • Australia

Study Locations

More Related Trials

Entities

Drugs
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02632760 on ClinicalTrials.gov